An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers.
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2010
At a glance
- Drugs PF 4764793 (Primary)
- Indications Obstructive airway disorders
- Focus Pharmacokinetics
- 12 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Sep 2009 New trial record